133 related articles for article (PubMed ID: 31748121)
1. Mechanisms and clinical course of cardiovascular toxicity of cancer treatment II. Hematology
Breccia M; Carver JR; Szmit S; Jurczak W; Salvatorelli E; Minotti G
Semin Oncol; 2019 Dec; 46(6):403-407. PubMed ID: 31748121
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Review of Cancer Drug-Induced Cardiotoxicity in Blood Cancer Patients: Current Perspectives and Therapeutic Strategies.
Costanzo V; Ratre YK; Andretta E; Acharya R; Bhaskar LVKS; Verma HK
Curr Treat Options Oncol; 2024 Apr; 25(4):465-495. PubMed ID: 38372853
[TBL] [Abstract][Full Text] [Related]
3. Antineoplastic drugs inducing cardiac and vascular toxicity - An update.
Barachini S; Ghelardoni S; Varga ZV; Mehanna RA; Montt-Guevara MM; Ferdinandy P; Madonna R
Vascul Pharmacol; 2023 Dec; 153():107223. PubMed ID: 37678516
[TBL] [Abstract][Full Text] [Related]
4. Heartbreaker: Detection and prevention of cardiotoxicity in hematological malignancies.
Vakilpour A; Lefebvre B; Lai C; Scherrer-Crosbie M
Blood Rev; 2024 Mar; 64():101166. PubMed ID: 38182490
[TBL] [Abstract][Full Text] [Related]
5. [Prophylaxis and treatment of hematological malignancy-associated thrombosis].
Ikezoe T
Rinsho Ketsueki; 2023; 64(9):1137-1143. PubMed ID: 37899193
[TBL] [Abstract][Full Text] [Related]
6. Understanding Myocardial Metabolism in the Context of Cardio-Oncology.
Liu J; Chen ZZ; Patel J; Asnani A
Heart Fail Clin; 2022 Jul; 18(3):415-424. PubMed ID: 35718416
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated thrombosis in hematologic malignancies.
Fukatsu M; Ikezoe T
Int J Hematol; 2024 May; 119(5):516-525. PubMed ID: 38270784
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Safety Assessment in Cancer Drug Development.
Oren O; Neilan TG; Fradley MG; Bhatt DL
J Am Heart Assoc; 2021 Dec; 10(24):e024033. PubMed ID: 34913360
[TBL] [Abstract][Full Text] [Related]
9. Vascular toxic effects of cancer therapies.
Herrmann J
Nat Rev Cardiol; 2020 Aug; 17(8):503-522. PubMed ID: 32218531
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 2.
Chang HM; Okwuosa TM; Scarabelli T; Moudgil R; Yeh ETH
J Am Coll Cardiol; 2017 Nov; 70(20):2552-2565. PubMed ID: 29145955
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management.
Barachini S; Buda G; Petrini I
J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541800
[TBL] [Abstract][Full Text] [Related]
12. Multi-Target Drugs for Blood Cancer in the Elderly: Implications of Damage and Repair in the Cardiovascular Toxicity.
Madonna R
Front Physiol; 2021; 12():792751. PubMed ID: 34950060
[No Abstract] [Full Text] [Related]
13. Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology.
Yeh ETH; Ewer MS; Moslehi J; Dlugosz-Danecka M; Banchs J; Chang HM; Minotti G
Semin Oncol; 2019 Dec; 46(6):397-402. PubMed ID: 31753424
[TBL] [Abstract][Full Text] [Related]
14. Cardio-oncological management of patients.
Cardinale DM; Barac A; Torbicki A; Khandheria BK; Lenihan D; Minotti G
Semin Oncol; 2019 Dec; 46(6):408-413. PubMed ID: 31784042
[TBL] [Abstract][Full Text] [Related]
15. Cardio-oncology in clinical studies and real life.
Dent SF; Suter TM; López-Fernández T; Opolski G; Menna P; Minotti G
Semin Oncol; 2019 Dec; 46(6):421-425. PubMed ID: 31767270
[TBL] [Abstract][Full Text] [Related]
16. Anthracycline-Induced Cardiotoxicity: Causes, Mechanisms, and Prevention.
Bhagat A; Kleinerman ES
Adv Exp Med Biol; 2020; 1257():181-192. PubMed ID: 32483740
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin protects cardiomyocyte from doxorubicin toxicity by modulating survivin expression through FOXO1 inhibition.
Oh J; Lee BS; Lim G; Lim H; Lee CJ; Park S; Lee SH; Chung JH; Kang SM
J Mol Cell Cardiol; 2020 Jan; 138():244-255. PubMed ID: 31866378
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of patients with newly diagnosed hematological malignancies referred for echocardiography.
Kępski J; Szmit S; Lech-Marańda E
Front Oncol; 2024; 14():1283831. PubMed ID: 38327743
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary hypertension in patients with multiple myeloma: A comprehensive review.
Maddipati V; Sankhyan P; Goswami DP; Mahajan A
Pulm Circ; 2023 Apr; 13(2):e12210. PubMed ID: 37063748
[TBL] [Abstract][Full Text] [Related]
20. The cancer patient and cardiology.
Zamorano JL; Gottfridsson C; Asteggiano R; Atar D; Badimon L; Bax JJ; Cardinale D; Cardone A; Feijen EAM; Ferdinandy P; López-Fernández T; Gale CP; Maduro JH; Moslehi J; Omland T; Plana Gomez JC; Scott J; Suter TM; Minotti G
Eur J Heart Fail; 2020 Dec; 22(12):2290-2309. PubMed ID: 32809231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
